Mike Napack Email

Director Sales & Marketing . Infraredx

Current Roles

Employees:
102
Revenue:
$25.6M
About
There are still broad swaths of uncharted territories concerning the role lipid core plaques play in heart disease. Now, you can achieve unparalleled insights with the Infraredx Dualpro IVUS+NIRS catheter and its accompanying Makoto Intravascular Imaging System, the only FDA-cleared dual-modality catheter and imaging system indicated for the detection of lipid core plaque (LCP). Anything else, and you are leaving valuable data on the table. For more information about the Makoto Imaging System or Dualpro IVUS+NIRS Catheter visit www.infraredx.com. Infraredx is an intravascular imaging company committed to advancing the diagnosis and management of coronary artery disease globally. Harnessing 30 years of research into the association between heart attacks and lipid-core plaques, Infraredx has been committed to the design, manufacture, and distribution of technologies that address the needs of practitioners and improve outcomes in the treatment of patients with coronary artery disease. With ongoing investment in several landmark global clinical trials, Infraredx's mission, to enable cardiologists to predict heart attacks and prevent them, continues.
Infraredx Address
34 Third Ave.
Burlington, MA
United States
Infraredx Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.